Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: Spain Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20071
20081
20111
20124
20138
20142
20153
20163
20172
20182
20191
20211
20222
20234
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Active, not recruiting4
Recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen12
Sanofi9
Merck Sharp & Dohme LLC5
Kowa Research Europe4
Novartis Pharmaceuticals4
Regeneron Pharmaceuticals2
AstraZeneca1
Daiichi Sankyo1
Hospital General Universitario Gregorio Marañon1
Kastle Therapeutics, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia44
Dyslipidemias10
Hyperlipidemias8
Hyperlipoproteinemia Type II6
Homozygous Familial Hypercholesterolemia3
Cardiovascular Diseases2
Coronary Artery Disease2
Aortic Valve Stenosis1
Arteriosclerosis1
Atherosclerosis1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.